<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02819713</url>
  </required_header>
  <id_info>
    <org_study_id>LTC-744-040111-Roelofs</org_study_id>
    <secondary_id>NL35454.091.11</secondary_id>
    <nct_id>NCT02819713</nct_id>
  </id_info>
  <brief_title>Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared With Guided Ultrasound Gel</brief_title>
  <official_title>Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared Guided Ultrasound Gel, a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial. One group (intervention group) will get in advance to&#xD;
      the prostate biopsy rectal approximately 5 cc Instillagel. And one group (control group) will&#xD;
      get in advance to the ultrasound -guided prostate biopsy rectal gel. Pain is measured using&#xD;
      the Numerical Rating Scale (NRS). The NRS is an imaginary line from 0 until 10. The 0 is no&#xD;
      pain and 10 is most worst imaginable pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Urologist within Rijnstate use both Instillagel and ultrasound gel during prostate biopsy.&#xD;
      According to the protocol, the ultrasound-guided prostate biopsy must be performed using&#xD;
      ultrasound gel. Some urologists departed from the protocols because they think that&#xD;
      Instillagel will give a pain reduction. With this research we investigate whether Instillagel&#xD;
      will have an effect on the pain perception bij the patients.&#xD;
&#xD;
      There will be three moments of pain measurements; Prior to het prostate biopsy. Immediately&#xD;
      after the prostate biopsy. And five to thirty minutes after the prostate biopsy, when the&#xD;
      patient is dressed and before the patient goes home.&#xD;
&#xD;
      Primary endpoint Pain measured by the Numeric Rating Scale&#xD;
&#xD;
      Secondary endpoints&#xD;
&#xD;
        -  Age of patient&#xD;
&#xD;
        -  Previous prostate biopsy&#xD;
&#xD;
        -  The number of biopsies taken&#xD;
&#xD;
        -  Presence of prostate cancer&#xD;
&#xD;
        -  Other complications as after prostate biopsy&#xD;
&#xD;
      The prostate biopsy will be performed by a urologist working at the outpatient clinic of&#xD;
      Rijnstate. The ultrasound equipment that will be used during prostate biopsy is Aloka&#xD;
      ProSound SSD-3500 or Aloka ProSound SSD or SV-3500 SX.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS score</measure>
    <time_frame>Three measurements before, just after and 5 -30 minutes after procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>age of patient</measure>
    <time_frame>Two weeks after the prostate biopsy.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Previous prostate biopsy</measure>
    <time_frame>Two weeks after the prostate biopsy.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of biopsies taken</measure>
    <time_frame>two weeks after prostate biopsy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications as after prostate biopsy</measure>
    <time_frame>two weeks after prostate biopsy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Prostate Biopsy</condition>
  <arm_group>
    <arm_group_label>ultrasound gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Instillagel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultrasound gel</intervention_name>
    <arm_group_label>ultrasound gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Instillagel</intervention_name>
    <arm_group_label>Instillagel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  outpatient ultrasound guide prostate biopsy&#xD;
&#xD;
          -  &gt; 40 years old.&#xD;
&#xD;
          -  Good knowledge of dutch language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  coagulation disorders&#xD;
&#xD;
          -  disorders of the rectum like hemorrhoids, anal fistula, proctitis, rectal polyps and&#xD;
             rectal cancer.&#xD;
&#xD;
          -  treated for active urinary tract infection&#xD;
&#xD;
          -  known of allergy to lidocaine&#xD;
&#xD;
          -  taking antidepressants&#xD;
&#xD;
          -  using anaesthetic agents&#xD;
&#xD;
          -  neurological disorders such as Parkinsons disease, hernias and spinal cord injury&#xD;
&#xD;
          -  treated with radiotherapy for prostate cancer&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marita van den Berg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rijnstate Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rijnstate location Arnhem</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <zip>6815 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>August 8, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2016</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate Biopsy</keyword>
  <keyword>NRS-score</keyword>
  <keyword>instillagel</keyword>
  <keyword>ultrasound conductive gel</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

